EA201000440A1 - Способ лечения центральной нервной системы и беспорядочных болей - Google Patents

Способ лечения центральной нервной системы и беспорядочных болей

Info

Publication number
EA201000440A1
EA201000440A1 EA201000440A EA201000440A EA201000440A1 EA 201000440 A1 EA201000440 A1 EA 201000440A1 EA 201000440 A EA201000440 A EA 201000440A EA 201000440 A EA201000440 A EA 201000440A EA 201000440 A1 EA201000440 A1 EA 201000440A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
nervous system
central nervous
disorderal
pains
Prior art date
Application number
EA201000440A
Other languages
English (en)
Other versions
EA021199B1 (ru
Inventor
Владимир Г. Граник
Варлерий А. Паршин
Ирина К. Сорокина
Original Assignee
Кофарм
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40084400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201000440(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Кофарм filed Critical Кофарм
Publication of EA201000440A1 publication Critical patent/EA201000440A1/ru
Publication of EA021199B1 publication Critical patent/EA021199B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Способ лечебного или профилактического лечения лиц, страдающих расстройствами периферической или центральной нервной системы, или условий или имеющих риск развития таких расстройств и условий, включающий применение фармакологически эффективного количества 3-фенилметиламинометилен пирролидинового-2,4-дион (I) или фармацевтически приемлемой соли, или пролекарства или сольвата их. Также раскрыто использование (I) для изготовления фармацевтического состава для лечения таких условий или расстройств.
EA201000440A 2007-09-06 2008-09-08 Способ терапевтического или профилактического лечения невропатической боли, хронической боли и фибромиалгии EA021199B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/851,229 US20090069405A1 (en) 2007-09-06 2007-09-06 Treatment of cns and pain disorders
PCT/IB2008/002378 WO2009031029A1 (en) 2007-09-06 2008-09-08 Treatment of cns and pain disorders

Publications (2)

Publication Number Publication Date
EA201000440A1 true EA201000440A1 (ru) 2011-06-30
EA021199B1 EA021199B1 (ru) 2015-04-30

Family

ID=40084400

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000440A EA021199B1 (ru) 2007-09-06 2008-09-08 Способ терапевтического или профилактического лечения невропатической боли, хронической боли и фибромиалгии

Country Status (10)

Country Link
US (1) US20090069405A1 (ru)
EP (1) EP2194979B1 (ru)
AP (1) AP2779A (ru)
AR (1) AR068380A1 (ru)
CL (1) CL2008002651A1 (ru)
EA (1) EA021199B1 (ru)
ES (1) ES2401938T3 (ru)
PL (1) PL2194979T3 (ru)
TW (1) TW200927095A (ru)
WO (1) WO2009031029A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU184787U1 (ru) * 2018-02-27 2018-11-08 Федеральное государственное бюджетное учреждение "33 Центральный научно-исследовательский испытательный институт" Министерства обороны Российской Федерации Стенд для проведения экспериментов по методике "принудительное плавание"

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2144918C1 (ru) * 1997-05-27 2000-01-27 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-бензиламинометиленпирролидин-2,4-дион и противосудорожное средство на его основе

Also Published As

Publication number Publication date
ES2401938T3 (es) 2013-04-25
TW200927095A (en) 2009-07-01
EP2194979A1 (en) 2010-06-16
EP2194979B1 (en) 2013-03-13
EA021199B1 (ru) 2015-04-30
AR068380A1 (es) 2009-11-11
WO2009031029A1 (en) 2009-03-12
CL2008002651A1 (es) 2009-03-20
US20090069405A1 (en) 2009-03-12
AP2010005218A0 (en) 2010-01-30
AP2779A (en) 2013-09-30
PL2194979T3 (pl) 2013-07-31

Similar Documents

Publication Publication Date Title
EP2331095A4 (en) CYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND METHOD OF USE THEREOF
EA200702200A1 (ru) Дигидротиенопиримидины для лечения воспалительных заболеваний
EA201000046A1 (ru) Замещенные имидазогетероциклы
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
DK1933833T3 (da) Terapi til behandling af overaktiv blære
ATE511392T1 (de) Verzögert freigesetzte orale dosierungsformen eines prodrugs von r-baclofen und behandlungsverfahren damit
EA201790406A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
WO2010045251A3 (en) Spiro-oxindole compounds and their use as therapeutic agents
EA201490163A1 (ru) Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения
FI3157527T3 (fi) Ezh2-inhibiittoreita lymfoman hoitoon
BRPI0519124A2 (pt) composto, mÉtodo para tratar, prevenir ou melhorar obesidade e doenÇas relacionadas e/ou sintomas das mesmas, composiÇço farmacÊutica, uso de composto, e, combinaÇço
WO2007087468A3 (en) Adiponectin for treatment of various disorders
EA200701296A1 (ru) 3,5-дизамещенные и 3,5,7-тризамещенные 3h-оксазоло- и 3h-тиазоло[4,5-d] пиримидин-2-оны и их пролекарства
EA200700909A1 (ru) Азаиндолкарбоксамиды
WO2005066337A3 (en) Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
HK1120441A1 (en) Drugs for treatment of ovarian cancer
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
WO2007087151A3 (en) Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction
BRPI0507120A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização
EA201071006A1 (ru) Набор, композиция, продукт или лекарственное средство для лечения нарушения познавательной способности
DK1663244T3 (da) Pteridin-derivater til behandling af TNF-alpha-beslægtede sygdomme
UA96447C2 (ru) Полиморфные формы (2s)-(4e)-n-метил-5-[3-(5-изопропоксипиридин)ил]-4-пентен-2-амина для лечения расстройств центральной нервной системы
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
EA200870469A1 (ru) Новые, содержащие нимесулид, фармацевтические композиции с низкой дозой, их получение и применение
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU